Stories written by
R Ramakumar
-
As Indian government offers some answers on Covaxin patent rights, more questions emerge
Since the government shares rights with Bharat Biotech, why did it not initiate steps to mass produce this vaccine in India over the past several months?
R Ramakumar
-
State governments can purchase only 25% of vaccines – belying Centre’s claim of equitable policy
There is also a clear case of discrimination in the new vaccine policy, given that the burden of deregulation is disproportionately borne by state governments.
R Ramakumar
-
Whose intellectual property is Bharat Biotech’s publicly funded Covaxin? India deserves an answer
If it turns out that the ICMR or the government owns the rights, the Indian public has the right to know how these were leveraged during a pandemic.
R Ramakumar
Trending
-
‘Saffronisation of Doordarshan’: After DD News unveils new logo, social media users express alarm
-
How Karnataka’s once-powerful Janata Dal Secular was reduced to a Hindutva offshoot
-
‘They built the Ram temple. That is bigger than providing jobs.’
-
Will bring back electoral bonds after wider consultations, says Nirmala Sitharaman
-
How Guwahati became the second-most polluted city in the world
-
India’s decision to liberalise vaccine sales likely to push up prices – and block access to millions
Besides, by making states responsible for buying vaccines, Modi’s government has deftly deflected possible criticism for future shortages.
R Ramakumar
-
After demonetisation: Is the thrust on digital transactions a violation of privacy?
‘As governments push cashless transactions, the potential for surveillance of the citizens rise.’
R Ramakumar